Advertisement

Topics

i3 Pharma Resourcing Company Profile

00:50 EDT 21st June 2018 | BioPortfolio

i3 Pharma Resourcing provides high-quality pharmaceutical personnel supported by world-class service. We draw on our clinical understanding and global resources tomatch the best individual for the unique needs of the job, then provide ongoing support and personal development.i3 Pharma Resourcing helps pharmaceutical companies meet their long-term and short-term resourcing needs by providing well-qualified pharmaceutical professionals, along with a high level of service. We serve the US, UK, Ireland, France, Germany, Spain, and Australia, drawing on a rich candidate pool.

Location

Suite 3, Level 1, 15 Blue Street
North Sydney
New South Wales
NSW 2060
Australia

Contact

Phone: 61 (0) 2 8666 9300
Fax: 61 (0) 2 8666 9333


News Articles [741 Associated News Articles listed on BioPortfolio]

CR Pharma to Acquire Jiangzhong Pharma for $667 Million

China Resources Pharma will pay $667 million to acquire all the outstanding shares of Jiangzhong Pharma, a listed company. Three weeks ago, CR Pharma announced plans to acquire a stake in the parent c...

#jobs #lifescience Accountant – Biotech / Pharma (Up to $70K)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Accountant – Biotech / Pharma (Up to $70K) .MA-Boston, Publicly Traded ...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

Verona Pharma plc: Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017

LONDON, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovati...

Verona Pharma plc: Verona Pharma Reports Operational Update and Financial Results for Full Year Ended December 31, 2017

LONDON, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (Verona Pharma), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative...

Tetra Bio-Pharma Inc.: Tetra Bio-Pharma Completes Acquisition of Remaining 20% Interest in PhytoPain Pharma Inc.

OTTAWA, ONTARIO -- (Marketwired) -- 03/19/18 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSX VENTURE: TBP)(OTCQB: TBPMF), today announced the completion of the previously announced acq...

Verona Pharma plc: Verona Pharma Provides Clinical Development Update

Accelerates top-line data readouts from ongoing clinical trials with RPL554 in COPD and CFLONDON, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (Verona Pharma), a cli...

Why pharma engagement on twitter matters!

The fact that thousands of stakeholders chose to follow pharma accounts on twitter deserves our attention. It says that there are people out there genuinely interested in what pharma has ...

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [25 Associated PubMed Articles listed on BioPortfolio]

Moving pharma contracting into the era of accountability.

Paediatric Consultation Liaison Psychiatry Services (PCLPS) -what are they actually doing?

Paediatric Consultation Liaison Psychiatry Services (PCLPS) are specialised services treating mental health difficulties co-morbid with medical problems.Standardised clinical data was retrieved from a...

A COLLABORATIVE PROJECT.

The Queensland government Department of Communities, Child Safety and Disability Services has funded Community Resourcing to establish the Community Care Smart Assistive Technology Collaborative (CCSA...

A guide to manufacturing CAR T cell therapies.

In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...

Rejuvenating the Face: An Analysis of 100 Absorbable Suture Suspension Patients.

Absorbable suture suspension (Silhouette InstaLift, Sinclair Pharma, Irvine, CA) is a novel, minimally invasive system that utilizes a specially manufactured synthetic suture to help address the issue...

Clinical Trials [79 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [768 Associated Companies listed on BioPortfolio]

i3 Pharma Resourcing

i3 Pharma Resourcing provides high-quality pharmaceutical personnel supported by world-class service. We draw on our clinical understanding and global resources tomatch the best individual for the uni...

Novella Clinical Resourcing

Novella Clinical Resourcing, a division of Novella Clinical Inc., provides customized, flexible clinical resourcing services including functional service provider (FSP) relationsh...

Trio Clinical Resourcing

Trio Clinical Resourcing, an Aptiv Solutions company, is an international biopharmaceutical and medical device resourcing company that provides flexible resourcing solutions to me...

Tsi Group

TSI Resourcing is part of the TSI Group - Technology Services International Limited. It was founded in 1987 with the aid of venture capital investment. The aim of the business was to provide a ‘one-...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

More Information about "i3 Pharma Resourcing" on BioPortfolio

We have published hundreds of i3 Pharma Resourcing news stories on BioPortfolio along with dozens of i3 Pharma Resourcing Clinical Trials and PubMed Articles about i3 Pharma Resourcing for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of i3 Pharma Resourcing Companies in our database. You can also find out about relevant i3 Pharma Resourcing Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record